P53 is a target gene of miR-223, UCMSC-EVs containing miR-223 reduced myocardial fibrosis and inflammation in MI rat models and accelerated angiogenesis of HUVECs through the p53/S100A9 axis (180). This evidence concerns the gene TP53 and myocardial infarction.